Stocks News

LAST PRICE
38.0700
TODAY'S CHANGE (%)
Trending Down-0.1100 (-0.2881%)

Bid / Lots
36.8500/ 3
Ask / Lots
39.5300/ 3
Open / Previous Close
37.5000 / 38.1800
Day Range
Low 37.4600
High 38.5700
52 Week Range
Low 36.7300
High 71.8500
Volume
873,494
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice - Contact Johnson Fistel, LLP, from 1 hour ago by GlobeNewswire
  1 hour ago by GlobeNewswire
  Companies Mentioned: NARI
- Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice -- Contact Johnson Fistel, LLP, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: NARI
  
  Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice -- Contact Johnson Fistel, LLP
  
  SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Inari Medical, Inc. (NASDAQ: NARI) ("Inari Medical"). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Inari Medical securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws.
Apr 22, 2024
- Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm, from 10:26AM ET on Monday Apr 22, 2024 by GlobeNewswire
  10:26AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: NARI
- Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm, from 10:26AM ET on Monday Apr 22, 2024 by Dow Jones
  10:26AM ET on Monday Apr 22, 2024 by Dow Jones
  Companies Mentioned: NARI
  
  Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
Apr 19, 2024
- NARI ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Inari Medical, Inc., from 10:47AM ET on Friday Apr 19, 2024 by Accesswire
  10:47AM ET on Friday Apr 19, 2024 by Accesswire
  Companies Mentioned: NARI
  NEW YORK, NY / ACCESSWIRE / April 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inari Medical, Inc. ("Inari Medical, Inc.") (NASDAQ:NARI) concerning possible violations of federal securities laws.

Today
- --Leerink Partners Upgrades Tandem Diabetes Care to Outperform Rating, Price Target is $45, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: TNDM
Apr 23, 2024
- TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Tuesday Apr 23, 2024 by GlobeNewswire
  9:00PM ET on Tuesday Apr 23, 2024 by GlobeNewswire
  Companies Mentioned: TNDM
- --Stifel Adjusts Price Target on Tandem Diabetes Care to $40 From $37, Maintains Buy Rating, from 9:06AM ET on Tuesday Apr 23, 2024 by MT Newswires
  9:06AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: TNDM
Apr 22, 2024
- RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024, from 4:05PM ET on Monday Apr 22, 2024 by GlobeNewswire
  4:05PM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: RXST
Apr 17, 2024
- ATEC to Report First Quarter Financial Results on May 7, 2024, from 9:00AM ET on Wednesday Apr 17, 2024 by Business Wire
  9:00AM ET on Wednesday Apr 17, 2024 by Business Wire
  Companies Mentioned: ATEC
Apr 11, 2024
- Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating, from 9:55AM ET on Thursday Apr 11, 2024 by MT Newswires
  9:55AM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: STAA
Apr 8, 2024
- Canaccord Genuity Raises Price Target on STAAR Surgical to $46 From $32, Maintains Hold Rating, from 10:20AM ET on Monday Apr 08, 2024 by MT Newswires
  10:20AM ET on Monday Apr 08, 2024 by MT Newswires
  Companies Mentioned: STAA
Apr 4, 2024
- RxSight Launches New Light Adjustable Lens Product, from 5:02PM ET on Thursday Apr 04, 2024 by MT Newswires
  5:02PM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: RXST
- RxSight Announces Commercial Launch of its Newest Light Adjustable Lens(TM), the LAL+(TM), and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting, from 4:05PM ET on Thursday Apr 04, 2024 by GlobeNewswire
  4:05PM ET on Thursday Apr 04, 2024 by GlobeNewswire
  Companies Mentioned: RXST
- Update: STAAR Surgical Shares Jump After Reporting Preliminary Fiscal Q1 Sales, from 12:25PM ET on Thursday Apr 04, 2024 by MT Newswires
  12:25PM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: STAA

Inari Medical Inc
NASDAQ:NARIUnited States

Search Criteria

Today

Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice - Contact Johnson Fistel, LLP, from 1 hour ago by GlobeNewswire

Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice -- Contact Johnson Fistel, LLP, from 1 hour ago by Dow Jones

Apr 22, 2024

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm, from 10:26AM ET on Monday Apr 22, 2024 by GlobeNewswire

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm, from 10:26AM ET on Monday Apr 22, 2024 by Dow Jones

Apr 19, 2024

NARI ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Inari Medical, Inc., from 10:47AM ET on Friday Apr 19, 2024 by Accesswire

Peers Headlines

Today

--Leerink Partners Upgrades Tandem Diabetes Care to Outperform Rating, Price Target is $45, from 10 hours ago by MT Newswires

Apr 23, 2024

TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Tuesday Apr 23, 2024 by GlobeNewswire

--Stifel Adjusts Price Target on Tandem Diabetes Care to $40 From $37, Maintains Buy Rating, from 9:06AM ET on Tuesday Apr 23, 2024 by MT Newswires

Apr 22, 2024

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024, from 4:05PM ET on Monday Apr 22, 2024 by GlobeNewswire

Apr 17, 2024

ATEC to Report First Quarter Financial Results on May 7, 2024, from 9:00AM ET on Wednesday Apr 17, 2024 by Business Wire

Apr 11, 2024

Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating, from 9:55AM ET on Thursday Apr 11, 2024 by MT Newswires

Apr 8, 2024

Canaccord Genuity Raises Price Target on STAAR Surgical to $46 From $32, Maintains Hold Rating, from 10:20AM ET on Monday Apr 08, 2024 by MT Newswires

Apr 4, 2024

RxSight Launches New Light Adjustable Lens Product, from 5:02PM ET on Thursday Apr 04, 2024 by MT Newswires

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens(TM), the LAL+(TM), and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting, from 4:05PM ET on Thursday Apr 04, 2024 by GlobeNewswire

Update: STAAR Surgical Shares Jump After Reporting Preliminary Fiscal Q1 Sales, from 12:25PM ET on Thursday Apr 04, 2024 by MT Newswires